--- title: "Venus Concept Inc. (VERO.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/VERO.US.md" symbol: "VERO.US" name: "Venus Concept Inc." industry: "Health Care Equipment" --- # Venus Concept Inc. (VERO.US) | Item | Detail | |------|--------| | Industry | Health Care Equipment | | Location | US Market | | Website | [www.venus.ai](https://www.venus.ai) | ## Company Profile Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive ... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-20T04:30:12.000Z **Overall: D (0.70)** **Industry**: Health Care Equipment | Metric | Value | |--------|-------| | Industry Ranking | 156 / 185 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -12.39% | | | Net Profit YoY | -8.91% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 0.26 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 687875.51 | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 58.88M | | **Multi Score**: D #### Profit Score: E | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -854.61% | E | | Profit Margin | -92.76% | E | | Gross Margin | 64.00% | A | #### Growth Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -12.39% | E | | Net Profit YoY | -8.91% | C | | Total Assets YoY | -14.74% | E | | Net Assets YoY | -70.51% | E | #### Cash Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -107.80% | D | | OCF YoY | -12.39% | E | #### Operating Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.88 | B | #### Debt Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 94.91% | E | ```chart-data:radar { "title": "Longbridge Financial Score - Venus Concept Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "E", "indicators": [ { "name": "ROE", "value": "-854.61%", "rating": "E" }, { "name": "Profit Margin", "value": "-92.76%", "rating": "E" }, { "name": "Gross Margin", "value": "64.00%", "rating": "A" } ] }, { "name": "Growth", "grade": "D", "indicators": [ { "name": "Revenue YoY", "value": "-12.39%", "rating": "E" }, { "name": "Net Profit YoY", "value": "-8.91%", "rating": "C" }, { "name": "Total Assets YoY", "value": "-14.74%", "rating": "E" }, { "name": "Net Assets YoY", "value": "-70.51%", "rating": "E" } ] }, { "name": "Cash", "grade": "D", "indicators": [ { "name": "Cash Flow Margin", "value": "-107.80%", "rating": "D" }, { "name": "OCF YoY", "value": "-12.39%", "rating": "E" } ] }, { "name": "Operating", "grade": "B", "indicators": [ { "name": "Turnover", "value": "0.88", "rating": "B" } ] }, { "name": "Security", "grade": "E", "indicators": [ { "name": "Gearing Ratio", "value": "94.91%", "rating": "E" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Inspire Medical (US.INSP) | A | B | A | A | B | A | | 02 | Delcath (US.DCTH) | C | A | A | A | A | A | | 03 | Intuitive Surgical (US.ISRG) | A | B | C | A | B | B | | 04 | Stryker (US.SYK) | A | B | C | C | B | B | | 05 | Boston Scientific (US.BSX) | B | B | C | C | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -0.01 | 46/181 | - | - | - | | PB | 0.26 | 6/181 | 1.92 | 1.34 | 0.99 | | PS (TTM) | 0.01 | 5/181 | 0.07 | 0.06 | 0.04 | | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview](https://longbridge.com/en/quote/VERO.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/VERO.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/VERO.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.